Outlook Therapeutics Inc. (OTLK)
NASDAQ: OTLK
· Real-Time Price · USD
1.40
-0.03 (-2.10%)
At close: May 07, 2025, 3:59 PM
1.41
1.08%
After-hours: May 07, 2025, 04:05 PM EDT
-2.10% (1D)
| Bid | 1.35 |
| Market Cap | 45.51M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -46.81M |
| EPS (ttm) | -2.48 |
| PE Ratio (ttm) | -0.56 |
| Forward PE | -1.71 |
| Analyst | Buy |
| Ask | 1.47 |
| Volume | 275,290 |
| Avg. Volume (20D) | 409,176 |
| Open | 1.43 |
| Previous Close | 1.43 |
| Day's Range | 1.36 - 1.50 |
| 52-Week Range | 0.87 - 9.25 |
| Beta | 0.39 |
About OTLK
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol OTLK
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for OTLK stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Outlook Therapeutics Inc. is scheduled to release its earnings on May 19, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 weeks ago
+1.75%
Outlook Therapeutics shares are trading higher aft...
Unlock content with
Pro Subscription
2 months ago
+8.7%
Outlook Therapeutics shares are trading higher after the company re-submitted its Biologics License Application for ONS-5010 in wet AMD to the FDA.
